CD8A and neoplasm: In the single-cohort, proof-of-concept Experiment 1, the FL models perform as well as (±1%) or better (>1%) than the centralized models in terms of mean F1 score for tumor segmentation and mean average precision (mAP) for CD8+ cell detection (Table 3a).